Eagle Bay Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-896
Closed -$106K 246
2024
Q4
$106K Sell
896
-61
-6% -$7.12K 0.07% 197
2024
Q3
$106K Buy
957
+3
+0.3% +$314 0.04% 271
2024
Q2
$93.8K Buy
954
+10
+1% +$1.02K 0.06% 238
2024
Q1
$106K Buy
944
+308
+48% +$33.2K 0.07% 197
2023
Q4
$64.1K Sell
636
-24
-4% -$2.38K 0.04% 266
2023
Q3
$57.3K Buy
660
+439
+199% +$39.7K 0.03% 385
2023
Q2
$20.9K Buy
221
+104
+89% +$8.79K 0.01% 524
2023
Q1
$8.83K Sell
117
-68
-37% -$5.13K ﹤0.01% 608
2022
Q4
$14.2K Buy
185
+166
+874% +$12.6K 0.01% 567
2022
Q3
$1K Hold
19
﹤0.01% 806
2022
Q2
$993 Buy
+19
New +$1.08K ﹤0.01% 911
2022
Q1
Sell
-10
Closed -$1K 398
2021
Q4
$1K Sell
10
-10
-50% -$490 ﹤0.01% 983
2021
Q3
$0 Buy
+20
New +$1.08K ﹤0.01% 1093

Other funds holding CAH

Eagle Bay Advisors's CAH Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Cardinal Health (CAH) in Q1 2025, closing a stake of 896 shares — an estimated $106K sold.

Eagle Bay Advisors first reported a position in CAH in Q3 2021 and held it in 13 quarters. The position peaked at $106K in Q1 2024. 1,148 funds tracked by Wall St. Rank hold CAH as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Cardinal Health position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 896 Cardinal Health shares in Q1 2025, an estimated $106K.
  • Eagle Bay Advisors first reported a position in Cardinal Health in Q3 2021 and held it in 13 quarters.
  • Eagle Bay Advisors's Cardinal Health position peaked at $106K in Q1 2024.
  • 1,148 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.